Percutaneous Endoscopic Gastrostomy (PEG) Tube market was valued at USD 665 million in 2024 and is projected to reach USD 1.02 billion by 2031, registering a CAGR of 6.2% during the forecast period. PEG tubes are critical medical devices enabling long-term enteral nutrition, medication administration, and gastric decompression for patients with swallowing difficulties or chronic gastrointestinal conditions. The market’s steady growth underscores the increasing prevalence of chronic diseases, aging populations, and the rising demand for home healthcare solutions.
Start Your Market Analysis with a Free Sample https://www.24lifesciences.com/download-sample/5623/percutaneous-endoscopic-gastrostomy-peg-tube-market
Market Highlights
Segmentation by Type
- Standard PEG Tubes: Widely used in hospitals and surgical centers for routine enteral access.
- Low-Profile PEG Tubes: Gaining traction due to patient comfort, discreet appearance, and reduced external tube length, improving the quality of life for long-term users.
- Balloon Retention Tubes: Popular in select cases for secure tube placement and ease of maintenance.
Low-profile PEG tubes are emerging as a preferred option due to design innovations that enhance comfort without compromising clinical efficacy.
Segmentation by Application
- Enteral Nutrition Delivery: Remains the dominant application, driven by the rising prevalence of chronic illnesses requiring long-term nutritional support.
- Medication Administration: Increasingly used for precise drug delivery in patients with swallowing difficulties.
- Gastric Decompression & Combination Therapies: Niche applications experiencing steady growth, particularly in post-surgical care.
Continuous product innovation, including anti-clogging designs and compatibility with various nutritional formulations, is driving adoption across applications.
Segmentation by End User
- Hospitals & Surgical Centers: The largest end-user segment due to the procedural nature of PEG tube placement.
- Home Healthcare Settings: Growing with the trend toward hospital-at-home models.
- Long-Term Care Facilities: Demand driven by chronic care requirements.
Hospitals lead the market, with emphasis on surgical precision, post-operative care protocols, and training programs for gastroenterologists and clinical teams.
Review the Complete Market Overview https://www.24lifesciences.com/percutaneous-endoscopic-gastrostomy-peg-tube-market-5623
Emerging Trends Shaping the Healthcare Market
The integration of artificial intelligence, digital health platforms, and remote patient monitoring is transforming PEG tube usage. AI-driven procedural guidance improves placement accuracy, while telehealth solutions facilitate patient monitoring in home healthcare settings. Additionally, sustainability initiatives in medical device manufacturing and biodegradable materials are gaining traction, aligning with regulatory focus on patient safety and environmental impact. Personalized enteral nutrition protocols, supported by data-driven healthcare platforms, are expected to further accelerate PEG tube adoption globally.
Regional Analysis
- North America: Dominates the global market due to advanced healthcare infrastructure, high procedural volumes, and strong adoption of innovative PEG technologies.
- Europe: Growth driven by aging populations, robust clinical adoption, and reimbursement support across major markets.
- Asia-Pacific: Witnessing rapid expansion due to increasing awareness of enteral nutrition, rising hospital infrastructure, and growing chronic disease prevalence.
- Rest of the World: Gradual growth fueled by emerging healthcare systems and increasing home healthcare adoption.
North America and Europe remain the largest revenue contributors, while Asia-Pacific offers significant untapped opportunities for market expansion.
Key Players & Competitive Landscape
The global PEG tube market is moderately consolidated, led by companies emphasizing technological innovation, procedural safety, and global distribution:
- Cook Medical (USA): Market leader with an extensive portfolio of endoscopic enteral access devices and innovations focused on procedural safety.
- Boston Scientific (USA): Competes through advanced tube materials and anti-reflux valve technologies.
- Medtronic plc (Ireland): Offers low-profile PEG devices and global distribution networks, expanding reach into emerging markets.
- ConMed Corporation (USA): Expanding through acquisitions and enhancement of PEG tube accessories.
- Fujifilm Holdings & Olympus Corporation (Japan): Leverage endoscopic imaging expertise to integrate visualization technologies with PEG placement systems.
Review the Complete Market Overview https://www.24lifesciences.com/percutaneous-endoscopic-gastrostomy-peg-tube-market-5623
Path Forward
The Percutaneous Endoscopic Gastrostomy (PEG) Tube market is expected to maintain steady growth through 2032, fueled by:
- Rising chronic disease prevalence requiring enteral nutrition
- Aging global population
- Technological innovations in tube design and materials
- Expansion of home healthcare and long-term care facilities
As healthcare systems worldwide continue to prioritize patient comfort, procedural safety, and personalized nutrition, PEG tube adoption will expand across hospital, outpatient, and home healthcare segments, driving consistent market growth.
Explore our related reports
About 24lifesciences
Founded in 2017, 24LifeScience has emerged as a trusted research and analytics partner for organizations operating within the global life sciences and chemical industries. Our core mission is to provide intelligent, future-ready insights that help clients stay ahead in an increasingly complex and innovation-driven market
International: +1(332) 2424 294 | Asia: +91 9425150513 (Asia)
Website: www.24lifesciences.com
Follow us on LinkedIn: www.linkedin.com/company/lifesciences24
- Single-Domain Heavy Chain Antibody Market - 2026-01-23
- Qianlie Antong Capsules Market - 2026-01-23
- Veterinary Amitraz Solution Market - 2026-01-23